Skip to Content

Paul Harari

From Human Oncology

Jump to: navigation, search

Harari Paul.png

Paul Harari




    Phone: (608) 263-5009

    Mailing Address:
    K4/336, Bx3684 Clinical Science Center
    600 Highland Ave
    Madison, WI 53792

Harari Lab Page

Harari Lab


  • Tufts University, Medford, Massachusetts, Biology: B.S.
  • University of Virginia School of Medicine, Charlottesville, Virginia, M.D.
  • Internal Medicine, University of California Davis, Sacramento, California.
  • Radiation Oncology and Cancer Biology, University of Arizona, Tucson, Arizona.


  • Head and neck cancer
  • Molecular modulation of radiation response
  • Conformal head and neck radiation treatment techniques
  • Molecular inhibition of growth factor receptor signaling

Fields of Interest

  • Radiation Oncology
  • Head and Neck Oncology
  • Oncology Training and Education


  • Professor & Chairman, Department of Human Oncology, University of Wisconsin School of Medicine & Public Health
  • Associate Director, UW Paul P. Carbone Comprehensive Cancer Center
  • Jack Fowler Professor of Human Oncology

Recent Publications

Paul M Harari, Jonathan Harris, Merrill S Kies, Jeffrey N Myers, Richard C Jordan, Maura L Gillison, Robert L Foote, Mitchell Machtay, Marvin Rotman, Deepak Khuntia, William Straube, Qiang Zhang, Kian Ang
Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234.
J. Clin. Oncol.: 2014;

Randall J Kimple, Paul M Harari
Is radiation dose reduction the right answer for HPV-positive head and neck cancer?
Oral Oncol.: 2013;

Shyh-Min Huang, Chimera R Peet, Jarob Saker, Chunrong Li, Eric A Armstrong, Michael Kragh, Mikkel W Pedersen, Paul M Harari
Sym004, a novel anti-EGFR antibody mixture augments radiation response in human lung and head and neck cancers.
Mol. Cancer Ther.: 2013;

Julian C Hong, Tim J Kruser, Vinai Gondi, Pranshu Mohindra, Donald M Cannon, Paul M Harari, Søren M Bentzen
Risk of Cerebrovascular Events in Elderly Patients After Radiation Therapy Versus Surgery for Early-Stage Glottic Cancer.
Int. J. Radiat. Oncol. Biol. Phys.: 2013;

Donald M Cannon, Heather M Geye, Gregory K Hartig, Anne M Traynor, Tien Hoang, Timothy M McCulloch, Peggy A Wiederholt, Richard J Chappell, Paul M Harari
Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy.
Head Neck: 2013;